Annual Cash & Cash Equivalents
$127.00 M
-$79.00 M-38.35%
31 December 2023
Summary:
Arcus Biosciences annual cash & cash equivalents is currently $127.00 million, with the most recent change of -$79.00 million (-38.35%) on 31 December 2023. During the last 3 years, it has fallen by -$46.41 million (-26.77%). RCUS annual cash & cash equivalents is now -38.35% below its all-time high of $206.00 million, reached on 31 December 2022.RCUS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$201.00 M
+$45.00 M+28.85%
30 September 2024
Summary:
Arcus Biosciences quarterly cash and cash equivalents is currently $201.00 million, with the most recent change of +$45.00 million (+28.85%) on 30 September 2024. Over the past year, it has increased by +$17.00 million (+9.24%). RCUS quarterly cash and cash equivalents is now -63.37% below its all-time high of $548.78 million, reached on 31 March 2022.RCUS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCUS Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.4% | +9.2% |
| 3 y3 years | -26.8% | +12.0% |
| 5 y5 years | +78.7% | +154.5% |
RCUS Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -38.4% | at low | -63.4% | +58.3% |
| 5 y | 5 years | -38.4% | +119.2% | -63.4% | +246.9% |
| alltime | all time | -38.4% | +119.2% | -63.4% | +246.9% |
Arcus Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $201.00 M(+28.8%) |
| June 2024 | - | $156.00 M(-15.7%) |
| Mar 2024 | - | $185.00 M(+45.7%) |
| Dec 2023 | $127.00 M(-38.3%) | $127.00 M(-31.0%) |
| Sept 2023 | - | $184.00 M(-20.0%) |
| June 2023 | - | $230.00 M(-3.4%) |
| Mar 2023 | - | $238.00 M(+15.5%) |
| Dec 2022 | $206.00 M(+39.2%) | $206.00 M(-5.4%) |
| Sept 2022 | - | $217.65 M(-20.2%) |
| June 2022 | - | $272.63 M(-50.3%) |
| Mar 2022 | - | $548.78 M(+270.8%) |
| Dec 2021 | $148.00 M | $148.00 M(-17.5%) |
| Sept 2021 | - | $179.43 M(-44.0%) |
| June 2021 | - | $320.48 M(-17.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $390.26 M(+125.0%) |
| Dec 2020 | $173.41 M(+199.3%) | $173.41 M(-21.8%) |
| Sept 2020 | - | $221.85 M(-22.2%) |
| June 2020 | - | $285.19 M(+323.6%) |
| Mar 2020 | - | $67.33 M(+16.2%) |
| Dec 2019 | $57.94 M(-18.5%) | $57.94 M(-26.7%) |
| Sept 2019 | - | $78.99 M(+3.8%) |
| June 2019 | - | $76.07 M(+11.0%) |
| Mar 2019 | - | $68.50 M(-3.6%) |
| Dec 2018 | $71.06 M(-27.8%) | $71.06 M(-5.1%) |
| Sept 2018 | - | $74.89 M(-55.9%) |
| June 2018 | - | $170.00 M(-14.2%) |
| Mar 2018 | - | $198.12 M(+101.3%) |
| Dec 2017 | $98.43 M(+51.1%) | $98.43 M |
| Dec 2016 | $65.16 M | - |
FAQ
- What is Arcus Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Arcus Biosciences?
- What is Arcus Biosciences annual cash & cash equivalents year-on-year change?
- What is Arcus Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Arcus Biosciences?
- What is Arcus Biosciences quarterly cash and cash equivalents year-on-year change?
What is Arcus Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of RCUS is $127.00 M
What is the all time high annual cash & cash equivalents for Arcus Biosciences?
Arcus Biosciences all-time high annual cash & cash equivalents is $206.00 M
What is Arcus Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, RCUS annual cash & cash equivalents has changed by -$79.00 M (-38.35%)
What is Arcus Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RCUS is $201.00 M
What is the all time high quarterly cash and cash equivalents for Arcus Biosciences?
Arcus Biosciences all-time high quarterly cash and cash equivalents is $548.78 M
What is Arcus Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, RCUS quarterly cash and cash equivalents has changed by +$17.00 M (+9.24%)